We are a privately owned company based in the UK. Our mission is to develop bioelectronic medicine which can help millions of people worldwide. We have over 30 patents covering our technology and its uses. Our team brings many years of clinical, technical, design and entrepreneurial expertise together to create the right mix for developing and bringing to market new bioelectronic devices.
Nigel Clarke, Chairman of the board
Chair, General Pharmaceutical Council
30 years’ experience in healthcare policy, regulation, investment and delivery. Former Chairman, SureCalm Healthcare Ltd.
Roly Allen, Managing Director
Entrepreneur with 20 years' experience across different sectors including technology and media.
Digby Emson, Non-Executive Director
Honorary Professor of Pharmacy Nottingham University. Fellow Royal Pharmaceutical Society. Member General Pharmaceutical Council. Chairman Buttercups Training. PAST Chairman Company Chemists Association. Former Executive Director Boots The Chemist.
James Van den Bergh, Non-Executive Director
James began his career at Merrill Lynch before transitioning into investment management in 2003. He was formerly a partner at Walter Capital Management LLP and Ivaldi Capital LLP and has recently been instrumental in making a number of investments, on behalf of Arrowgrass Capital Partners LLP, in the alternative finance space.
We are a fast-growing company and so are always looking for the best people to join our team.